Agape ATP Corporation (NASDAQ:ATPC) Short Interest Update

Agape ATP Corporation (NASDAQ:ATPC) was the target of a large growth in short interest in May. As of May 29th, there was short interest totaling 314,161 shares, a growth of 5,924.2% from the May 14th total of 5,215 shares. Based on an average daily trading volume, of 12,517,087 shares, the short-interest ratio is currently 0.0 days. Currently, 32.0% of the shares of the stock are short sold.

Wall Street Analysts Forecast Growth

ATPC has been the subject of a number of recent research reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Agape ATP in a research note on Friday, May 22nd. Wall Street Zen raised Agape ATP from a “sell” rating to a “hold” rating in a research note on Sunday, April 12th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

Agape ATP Price Performance

NASDAQ:ATPC opened at $3.01 on Thursday. The firm has a market capitalization of $3.01 million, a price-to-earnings ratio of -2.26 and a beta of 0.08. Agape ATP has a 1 year low of $1.72 and a 1 year high of $85.50. The business has a 50 day simple moving average of $2.82 and a 200-day simple moving average of $8.95.

Agape ATP (NASDAQ:ATPC) last posted its quarterly earnings data on Friday, May 15th. The company reported ($0.33) earnings per share (EPS) for the quarter. The company had revenue of $0.27 million during the quarter. Agape ATP had a negative net margin of 125.89% and a negative return on equity of 8.43%.

Institutional Investors Weigh In On Agape ATP

A hedge fund recently raised its stake in Agape ATP stock. Citadel Advisors LLC increased its holdings in shares of Agape ATP Corporation (NASDAQ:ATPC) by 95.7% in the third quarter, according to its most recent filing with the SEC. The fund owned 65,130 shares of the company’s stock after acquiring an additional 31,849 shares during the period. Citadel Advisors LLC owned about 0.13% of Agape ATP worth $82,000 at the end of the most recent quarter. Institutional investors own 0.01% of the company’s stock.

About Agape ATP

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.